Target intelligence / Profile preview

CLYBL antisense RNA 2 (CLYBL-AS2)

Target
CLYBL-AS2
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

CLYBL antisense RNA 2 (CLYBL-AS2) is a long non-coding RNA gene transcribed in the antisense direction relative to the CLYBL protein-coding gene. As an antisense lncRNA, it is expected to be involved in the regulation of gene expression through RNA-RNA or RNA-DNA interactions, but its specific biological function and physiological roles remain unclear. No direct association with human disease or actionable therapeutic targeting is reported. There are no known drugs, clinical indications, or biomarker uses for CLYBL-AS2, and it is not classified as an enzyme, receptor, transporter, or other classical drug target[1][4][6][9]. Notes: - CLYBL, a neighboring protein-coding gene, is a mitochondrial enzyme with malate synthase and β-methylmalate synthase activity[7], but CLYBL-AS2 is non-coding and unrelated to these enzymatic functions. - As with many antisense RNAs, CLYBL-AS2 may modulate the expression of its sense counterpart, but there is no published functional evidence or disease association at this time[1][4][6]. - No errors, misspellings, or spurious information were encountered for this target name.

Other names
CLYBL antisense RNA 2 (non-protein coding)CLYBL-AS2
02

Biological functions

Other (likely regulatory RNA function, uncharacterized)

Beyond the preview

Go deeper on CLYBL antisense RNA 2 (CLYBL-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLYBL antisense RNA 2 (CLYBL-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call